Fidson Healthcare Plc, Nigeria’s leading pharmaceutical company, has inked a strategic cooperation memorandum with three Chinese firms to establish a cutting-edge pharmaceutical plant in Lagos.
Daily Report Nigeria reports that the firms include Jiangsu Aidea Pharma, Nanjing PharmaBlock, and the China-Africa Development Fund.
The facility, set to be located in the Lekki Free Trade Zone, aims to enhance Africa’s self-sufficiency in healthcare, particularly in combating HIV, according to a statement from Fidson on Friday.
Fidson explained that this partnership exemplifies international cooperation in addressing critical medical challenges.
ATTENTION: Click “HERE” to join our WhatsApp group and receive News updates directly on your WhatsApp!
READ ALSO: 400 Illegal Drugs Stores Shut Down By Pharmacy Council In Cross River
The agreement was formalised during a visit to China by a Nigerian delegation led by Fidson’s Founder and Managing Director, Dr Fidelis Ayebae.
This followed an earlier visit to Nigeria by Dr Heliang Fu, Chairman of Jiangsu Aidea Pharma, who toured the Lekki Free Trade Zone, the designated site for the new facility.
Dr Fu said:
“This collaboration marks a significant step for Chinese pharmaceutical players in their commitment to global medical cooperation. By integrating our expertise and experience in innovative drugs, we are confident in enhancing the well-being of African patients.”
Dr Ayebae:
“We eagerly anticipate this collaboration and believe that the complementary strengths of all parties will inject new vitality into the healthcare sector in Africa, particularly in addressing the medical needs of over 1.9 million HIV-infected individuals in Nigeria, a key focus for Aidea Pharma.”
